Conference Coverage

Data presented demonstrates use of DCISionRT and its response subtype (Rst) was able to identify women with ductal carcinoma in situ (DCIS)  (Stage 0 breast cancer) who remain at an elevated risk of recurrence despite receiving breast conserving surgery (BCS) and radiation therapy (RT).
News | Radiation Therapy
PreludeDx Presents DCIS Precision Medicine Study Results at ASTRO 2021 Annual Meeting

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast ...

Time November 02, 2021
arrow
18F-FDG PET in patients with long-COVID syndrome. A and B: Transaxial sections of group averaged, spatially normalized 18F-FDG PET scans in patients with long-COVID syndrome (A) and control patients (B). C: The pattern expression score (PES; *adjusted for age and sex, for illustration purposes) of the previously established COVID-19-related spatial covariance pattern was not significantly different between patients with long-COVID syndrome and control patients. Boxplots (grey), as well as individual values
News | Coronavirus (COVID-19)
Molecular Imaging Suggests Long-COVID Symptoms may be Caused by Fatigue

November 1, 2021 — Long-term cognitive problems after a COVID-19 diagnosis may be a result of fatigue rather than ...

Time November 01, 2021
arrow
News | Stereotactic Body Radiation Therapy (SBRT)
Serial Radiation Therapy is Safe and Effective as Alternative Treatment to Systemic Therapy for Kidney Cancer

October 29, 2021 — In a new single-arm study, researchers at The University of Texas MD Anderson Cancer Center reported ...

Time October 29, 2021
arrow
Elekta Harmony radiation therapy system at ASTRO 2021.
360 Photos | Radiation Therapy
360 Degree View of the Harmony Radiation Therapy System at ASTRO 2021

This is a virtual tour of the New Elekta Harmony radiation therapy system at the American Society of Radiation Oncology ...

Time October 28, 2021
arrow
In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.
News | Radiation Therapy
Optimizing Preoperative Radiation Therapy in High-risk Sarcoma

October 28, 2021 — In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found ...

Time October 28, 2021
arrow
An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides strong evidence for the addition of androgen deprivation therapy (ADT) to definitive radiotherapy (RT) for the treatment of prostate cancer, with the projection that adding ADT to the treatment of 10-15 men would prevent the development of distant metastasis in one man.
News | Prostate Cancer
International Meta-analysis Quantifies Impact of Three Prostate Cancer Therapy Intensification Strategies

October 28, 2021 — An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides ...

Time October 28, 2021
arrow
ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society, held October 24-27, 2021 in Chicago.
News | Stereotactic Body Radiation Therapy (SBRT)
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients

October 28, 2021 — ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer ...

Time October 28, 2021
arrow
Chest radiograph without Auto Lung Nodule Detection (ALND) and chest radiograph with lung nodule marked.
News | Artificial Intelligence
Samsung Receives FDA Clearance for AI Algorithms that Detect Lung Nodules in Chest X-rays

October 28, 2021 — NeuroLogica Corp. announced it has received Food and Drug Administration (FDA) 510(k) clearance for ...

Time October 28, 2021
arrow
Carestream’s AI features are powered by Eclipse—the engine behind the company’s cutting-edge imaging software platforms—that uses proprietary algorithms and AI to amplify the value of the entire imaging chain.
News | Artificial Intelligence
Carestream Showcases Artificial Intelligence Innovation at RSNA 2021

October 27, 2021 — Carestream Health will highlight the imaging and workflow value of artificial intelligence (AI) in ...

Time October 27, 2021
arrow
Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment.
News | Treatment Planning
Prevencio and Memorial Sloan Kettering Cancer Center Data Demonstrates Significant Correlation of AI-driven HART CVE Blood Test Scores with Development of Adverse Heart Events Following Cancer Radiation Treatment

October 27, 2021 — Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE ...

Time October 27, 2021
arrow
Analysis finds that insurance approval processes create substantial time and cost burdens despite most treatments being delivered as originally prescribed
News | ASTRO
New Study Estimates Prior Authorization Costs Radiation Oncology Clinics More Than $40M Each Year

October 27, 2021 — The time required to secure prior authorization approvals for radiation therapy treatments equates to ...

Time October 27, 2021
arrow
A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer.
News | Radiation Oncology
Intervention Eliminates Black-white Gaps in Survival from Early-stage Breast and Lung Cancer

October 25, 2021 — A new study shows that system-level changes to the way cancer care is delivered can also eliminate ...

Time October 25, 2021
arrow
A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.
News | Prostate Cancer
Genetic Biomarker Test Predicts Recurrence and Survival Outcomes for Men with High-risk Prostate Cancer

October 25, 2021 — A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk ...

Time October 25, 2021
arrow
 Using fewer—but higher—doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.
News | Prostate Cancer
Shortened Course of Radiation Therapy Offers Similar Long-term Side Effects Following Prostate Removal Surgery

October 25, 2021 — Using fewer—but higher—doses of radiation to treat men with prostate cancer who had their prostates ...

Time October 25, 2021
arrow
High-dose radiation therapy can be used to lengthen progression-free survival for people with advanced lung cancer when systemic therapy has not fully halted the growth or spread of metastases, according to a new study.
News | Stereotactic Body Radiation Therapy (SBRT)
High-dose Radiation Thwarts Tumor Growth in Patients with Advanced Lung Cancer

October 24, 2021 — High-dose radiation therapy can be used to lengthen progression-free survival for people with ...

Time October 24, 2021
arrow
People with liver cancer awaiting transplantation could benefit from non-invasive radiation treatments but are rarely given this therapy, according to a new analysis of U.S. national data
News | Radiation Therapy
External-beam Radiation Therapy Underused for People with Liver Cancer Awaiting Transplant

October 24, 2021 — People with liver cancer awaiting transplantation could benefit from non-invasive radiation ...

Time October 24, 2021
arrow
Blue Wolf Capital Partners LLC, a New York-based private equity firm, today announced it has entered into an agreement to acquire CIVCO Radiotherapy, a global leader of radiotherapy patient positioning and immobilization equipment, from Roper Technologies, Inc.
News | Radiology Business
Blue Wolf Capital to Acquire CIVCO Radiotherapy from Roper Technologies

October 22, 2021 — Blue Wolf Capital Partners LLC, a New York-based private equity firm, today announced it has entered ...

Time October 22, 2021
arrow
At this year’s ASTRO 2021 event, GE Healthcare will showcase over 15 innovative multi-modality radiation therapy solutions, offering medical practitioners imaging tools and support they need to improve patient-centered care and advance the practice of precision medicine.
News | Radiation Therapy
GE Healthcare Advances Precision Radiation Therapy Solutions with New Products, Partners and Solutions at #ASTRO21

October 22, 2021 — At this year’s ASTRO 2021 event, GE Healthcare will showcase over 15 innovative multi-modality ...

Time October 22, 2021
arrow
News | Proton Therapy
RaySearch and Mevion to Develop Next-Generation Treatment Planning Techniques for FLASH Proton Radiotherapy Treatment

October 22, 2021 — RaySearch Laboratories AB and Mevion Medical Systems, two companies that are leading the field of ...

Time October 22, 2021
arrow
Bipartisan oversight letters from House, Senate and caucus leaders articulate concerns with draconian cuts in the proposed Radiation Oncology Model and Medicare physician fee schedule
News | Radiation Oncology
Senators and representatives unite to call on CMS to protect patient access to high-quality radiation treatments

October 22, 2021 — Eighty-five members of Congress have joined together to issue bipartisan, bicameral oversight letters ...

Time October 22, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now